186 related articles for article (PubMed ID: 10675700)
21. Mechanisms of drug release in citrate buffered HPMC matrices.
Pygall SR; Kujawinski S; Timmins P; Melia CD
Int J Pharm; 2009 Mar; 370(1-2):110-20. PubMed ID: 19100822
[TBL] [Abstract][Full Text] [Related]
22. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release.
Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC
J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998
[TBL] [Abstract][Full Text] [Related]
23. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
Rujivipat S; Bodmeier R
Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
[TBL] [Abstract][Full Text] [Related]
24. Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration.
Fu XC; Wang GP; Liang WQ; Chow MS
J Control Release; 2004 Mar; 95(2):209-16. PubMed ID: 14980769
[TBL] [Abstract][Full Text] [Related]
25. Oral mucosal bioadhesive tablets of pectin and HPMC: in vitro and in vivo evaluation.
Miyazaki S; Kawasaki N; Nakamura T; Iwatsu M; Hou WM; Attwood D
Int J Pharm; 2000 Aug; 204(1-2):127-32. PubMed ID: 11011995
[TBL] [Abstract][Full Text] [Related]
26. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
27. In-vitro and in-vivo erosion profiles of hydroxypropylmethylcellulose (HPMC) matrix tablets.
Ghimire M; Hodges LA; Band J; O'Mahony B; McInnes FJ; Mullen AB; Stevens HN
J Control Release; 2010 Oct; 147(1):70-5. PubMed ID: 20600400
[TBL] [Abstract][Full Text] [Related]
28. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
Nokhodchi A; Aliakbar R; Desai S; Javadzadeh Y
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):262-9. PubMed ID: 20451361
[TBL] [Abstract][Full Text] [Related]
29. Biointerfacial phenomena of amlodipine buccomucosal tablets of HPMC matrix system containing polyacrylate polymer/β-cyclodextrin: Correlation of swelling and drug delivery performance.
Panda B; Subhadarsini R; Mallick S
Expert Opin Drug Deliv; 2016; 13(5):633-43. PubMed ID: 26878690
[TBL] [Abstract][Full Text] [Related]
30. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
Emara LH; Taha NF; Badr RM; Mursi NM
Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
[TBL] [Abstract][Full Text] [Related]
31. Synchronized release of sulpiride and sodium decanoate from HPMC matrices: a rational approach to enhance sulpiride absorption in the rat intestine.
Baluom M; Friedman M; Assaf P; Haj-Yehia AI; Rubinstein A
Pharm Res; 2000 Sep; 17(9):1071-6. PubMed ID: 11087038
[TBL] [Abstract][Full Text] [Related]
32. The effect of controlled release tablet performance and hydrogel strength on in vitro/in vivo correlation.
Roshdy MN; Schnaare RL; Sugita ET; Schwartz JB
Pharm Dev Technol; 2002 May; 7(2):155-68. PubMed ID: 12066571
[TBL] [Abstract][Full Text] [Related]
33. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
Li FQ; Hu JH
Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
[TBL] [Abstract][Full Text] [Related]
34. Designing HPMC matrices with improved resistance to dissolved sugar.
Williams HD; Ward R; Culy A; Hardy IJ; Melia CD
Int J Pharm; 2010 Nov; 401(1-2):51-9. PubMed ID: 20858538
[TBL] [Abstract][Full Text] [Related]
35. [Effect of the sustained release excipients on the release rate of ginsenoside Rg1 and ginsenoside Rb1 in sustained-release tablet of Panax notoginsenosides].
Wu Q; Chen XC; Du SY
Zhongguo Zhong Yao Za Zhi; 2004 Oct; 29(10):944-7. PubMed ID: 15631077
[TBL] [Abstract][Full Text] [Related]
36. New comprehensive mathematical model for HPMC-MCC based matrices to design oral controlled release systems.
Saeidipour F; Mansourpour Z; Mortazavian E; Rafiee-Tehrani N; Rafiee-Tehrani M
Eur J Pharm Biopharm; 2017 Dec; 121():61-72. PubMed ID: 28951063
[TBL] [Abstract][Full Text] [Related]
37. Drug release kinetics from tablet matrices based upon ethylcellulose ether-derivatives: a comparison between different formulations.
Khan GM; Meidan VM
Drug Dev Ind Pharm; 2007 Jun; 33(6):627-39. PubMed ID: 17613027
[TBL] [Abstract][Full Text] [Related]
38. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics.
Kim H; Fassihi R
J Pharm Sci; 1997 Mar; 86(3):323-8. PubMed ID: 9050800
[TBL] [Abstract][Full Text] [Related]
39. The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation.
McConville JT; Ross AC; Chambers AR; Smith G; Florence AJ; Stevens HN
Eur J Pharm Biopharm; 2004 May; 57(3):541-9. PubMed ID: 15093604
[TBL] [Abstract][Full Text] [Related]
40. Kinetic release of theophylline from hydrophilic swellable matrices.
Vargas CI; Ghaly ES
Drug Dev Ind Pharm; 1999 Sep; 25(9):1045-50. PubMed ID: 10518245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
